Prevalence of Diabetes Mellitus and Its Associated Unfavorable Outcomes in Patients With Acute Respiratory Syndromes Due to Coronaviruses Infection: A Systematic Review and Meta-Analysis.
Isabel Pinedo PadillaMagaly Flores-FernándezMarlon Yovera-AldanaClaudia Gutiérrez-OrtizPaolo Zegarra-LizanaClaudio Intimayta-EscalanteCristian Moran-MariñosCarlos Alva-DiazKevin Pacheco-BarriosPublished in: Clinical medicine insights. Endocrinology and diabetes (2020)
The prevalence of DM in patients with acute respiratory syndrome due to coronaviruses is high, predominantly with MERS-Cov infection. The unfavorable health outcomes are frequent in this subset of patients. Well-powered and population-based studies are needed, including detailed DM clinical profile (such as glycemic control, DM complications, and treatment regimens), comorbidities, and SARS-Cov-2 evolution to reevaluate the worldwide prevalence of this comorbidity and to typify clinical phenotypes with differential risk within the subpopulation of DM patients.